title: The Edmonton experience with venovenous extracorporeal membrane oxygenation.
abstract: OBJECTIVE
  Despite the proven effectiveness of venovenous extracorporeal membrane oxygenation (VV ECMO) in the treatment of neonates with severe respiratory failure, this technique is not widely used. The purpose of this study was to assess the authors' policy of preferred use of VV ECMO with a cephalad catheter and to compare the results with those of the Extracorporeal Life Support Organization (ELSO) Registry.
  
  
  METHODS
  Charts of neonatal ECMO candidates were reviewed retrospectively. Data were collected for gestational age, birth weight, and diagnosis. Severity of illness was assessed by oxygenation index, lactate levels, and inotropic requirements before cannulation. Patients were divided into three groups: venovenous (VV), venoarterial (VA), and VV to VA ECMO. A cephalad catheter was inserted in the distal part of the jugular vein.
  
  
  RESULTS
  Sixty-five neonates were supported with ECMO. Cannulation with a double lumen venovenous (VVDL) catheter was attempted in 63 neonates and successfully accomplished in 57. A survival rate of 86% was observed in neonates initially placed on VV ECMO. Five neonates initially placed on VV ECMO underwent conversion to VA ECMO.
  
  
  CONCLUSIONS
  This study showed that the authors' preferred policy of VV ECMO did not result in an increase in mortality rate based on a comparison with ELSO data. VV ECMO with a cephalad catheter provides adequate support for unstable neonates with respiratory failure.
authors.affiliation: Royal Alexandra Hospital, Department of Pediatrics, University of Alberta, Edmonton, Canada.
authors.forename: H C
authors.initials: HC
authors.lastname: Osiovich
authors.forename: A
authors.initials: A
authors.lastname: Peliowski
authors.forename: W
authors.initials: W
authors.lastname: Ainsworth
authors.forename: P C
authors.initials: PC
authors.lastname: Etches
mesh_terms: D000416:Alberta; D015199:Extracorporeal Membrane Oxygenation / Q000379:methods*; D006801:Humans; D007231:Infant, Newborn; D012127:Respiratory Distress Syndrome, Newborn / Q000401:mortality / Q000628:therapy*; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome